New MRI scan could predict pancreatic cancer treatment success
NCT ID NCT06600906
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental MRI scan that uses a special contrast agent called hyperpolarized carbon-13 pyruvate to see how pancreatic tumors process nutrients. The goal is to find out if this scan can predict treatment response better than standard MRIs. About 70 adults with advanced pancreatic cancer will be scanned before and after four weeks of standard treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Hyperpolarized carbon-13 pyruvate
What this could lead to
If successful, this scan could help doctors quickly tell if a pancreatic cancer treatment is working, allowing them to adjust therapy sooner.
What could go wrong
This is an early study with only 70 participants, so results may not apply to everyone. The scan is experimental and may not prove better than current methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94143, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact